This study is looking at ways to treat orthostatic hypotension (a sudden drop in blood pressure when standing up) in people with spinal cord injury. Researchers are testing a drug called Midodrine Hydrochloride to find the best dose to increase and stabilize your blood pressure when you change positions. They also want to understand how different treatments affect symptoms like fatigue and discomfort. You may be able to join if you are 18 to 60 years old, have a traumatic spinal cord injury (C1-T6 level) that happened at least 12 months ago, and are not able to walk or use a ventilator. The study aims to enroll 25 participants, but its current recruitment status is unclear. Success will be measured by changes in your systolic blood pressure (the top number in a blood pressure reading) over 3 years.

Study design

This is an interventional study planning to enroll 25 participants. The phase of the study is not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your systolic blood pressure will be measured at 3 years to see the long-term effects of the treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.